Understanding Central Retinal Vein Occlusion

Central Retinal Vein Occlusion

Understanding Central Retinal Vein Occlusion

This section explains what CRVO is and why early recognition matters.

Around 0.13 percent of adults ages 30 to 89 in the United States are affected, which means thousands of people in our region live with CRVO.

The central retinal vein can become partially or completely obstructed by a blood clot. When drainage slows, blood and fluid leak into the retina, causing swelling and blurred vision, especially in the macula.

Types of CRVO

Types of CRVO

CRVO is classified into two primary forms, each with different levels of severity and outlook.

This milder type accounts for about 70 percent of cases. Vision may remain better than 20/200, and some patients improve, but careful follow-up is needed because it can progress.

This severe form sharply reduces blood flow, leading to oxygen loss, extensive retinal hemorrhages, and vision often worse than 20/200. Prompt care is vital to lower the risk of lasting damage.

Impact on Vision

Impact on Vision

CRVO can quickly change how clearly you see, especially in one eye.

Leakage into the macula causes distortion or hazy vision that may appear without warning.

Prolonged poor circulation can damage retinal nerve cells, sometimes leading to permanent vision loss if not treated early.

Signs and Symptoms

Knowing what to watch for helps you seek help right away.

The most common complaint, which can involve the entire field or only the center.

Some people notice a rapid decline, and complete loss is possible in severe cases.

Dark spots or squiggles appear when leaked blood casts shadows inside the eye.

Less frequently, pressure or redness occurs, especially with advanced disease.

CRVO Evaluation

CRVO Evaluation

Several painless tests help confirm the diagnosis and guide treatment.

Dilating drops allow a clear view of the retina so the specialist can spot bleeding, swelling, and vessel changes.

An OCT scan captures detailed cross-sectional images, revealing the extent of macular edema and tracking response to therapy.

A fluorescent dye highlights blood flow, pinpointing blocked or leaking vessels.

Standard acuity and peripheral vision checks help determine whether the CRVO is ischemic or non-ischemic.

Treatment Options

Treatment Options

Therapy focuses on reducing swelling, improving circulation, and preventing complications.

Medications such as bevacizumab, ranibizumab, or aflibercept lower vascular endothelial growth factor, decreasing leakage and macular edema.

Triamcinolone or dexamethasone implants ease inflammation when swelling persists, though eye pressure and cataracts are monitored closely.

Panretinal photocoagulation treats areas lacking blood flow, reducing the drive for abnormal vessel growth.

In select cases, agents like tissue plasminogen activator or surgical approaches such as pars plana vitrectomy are considered.

Recent Statistics

Recent Statistics

Current research highlights why swift management is essential.

More than 90 percent of ischemic CRVO cases result in vision worse than 20/200, while only about 10 percent of non-ischemic cases regain full vision.

Studies show up to 34 percent of non-ischemic cases convert to ischemic within three years, underscoring the need for regular monitoring.

Risk Factors

Risk Factors

Several health and lifestyle issues raise the likelihood of CRVO.

Chronic hypertension narrows retinal veins and increases clot risk.

Elevated blood sugar damages blood vessels throughout the body, including those in the retina.

High intraocular pressure can compress the central retinal vein.

Hardened arteries may impair retinal circulation.

Tobacco use and sedentary habits worsen vascular health and clot risk.

Blood-clotting disorders, autoimmune diseases, and certain medications have also been linked to CRVO.

Complications

Complications

Untreated CRVO can lead to additional eye problems.

Persistent swelling of the macula blurs vision and can cause permanent loss if not controlled.

Fragile new blood vessels may raise eye pressure, causing pain and further vision loss.

Causes of CRVO

Multiple mechanisms can block the central retinal vein.

A thrombus inside the vein is the most common trigger, especially in people with clotting disorders.

Atherosclerosis or artery compression reduces blood flow and raises blockage risk.

Elevated pressure within the eye can constrict the vein’s pathway.

Diabetes, hypertension, high cholesterol, smoking, and obesity increase susceptibility.

Inflammatory diseases, infections, migraines, or trauma may lead to CRVO, particularly in younger patients.

Frequently Asked Questions

Frequently Asked Questions

Patients often have similar concerns when learning about CRVO.

Your retinal evaluation will determine whether the condition is ischemic or non-ischemic and the extent of any damage.

The specialist will review each option, explaining how injections, laser therapy, or other measures may help and what side effects to monitor.

Visits are typically frequent at first, then spaced out as your eye stabilizes, ensuring timely detection of changes.

OCT scans or angiography may be repeated to track swelling and blood flow over time.

Managing blood pressure, blood sugar, and cholesterol, along with quitting smoking and staying active, can lower future risk.

Your Eye Health Partner

Your Eye Health Partner

Our team is committed to guiding you through diagnosis, treatment, and ongoing care so you feel informed and supported. If you notice sudden changes in vision, reach out promptly, and remember that early attention can make a lasting difference.

Contact Us

Google review
4.5
(2196)

Monday: 8AM-4:30PM
Tuesday: 8AM-7PM
Wednesday: 8AM-4:30PM
Thursday: 8AM-7PM
Friday: 7:30AM-4:30PM
Saturday: 8AM-1:30PM
Sunday: Closed